Total weight loss at 48-68 weeks on the combination is difficult to predict without clinical trial data, but based on individual compound data (retatrutide at 24-28.7% and the additive benefit seen with CagriSema), a reasonable estimate for the combination is 25-35% total body weight reduction in high responders
If you experience fatigue or paradoxical symptoms like headaches, it's likely a detoxification reaction
Long-term safety remains largely unknown due to limited research and regulation
The Lancet Neurology, 18(7), 684696
Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Purity & Documentation Data Sheet (279 KB) SDS (254 KB) English - EN (254 KB) Franais - FR (254 KB) Deutsch - DE (254 KB) Norwegian - NO (254 KB) Espaol - ES (254 KB) Swedish - SV (254 KB) Italian - IT (254 KB) Korean - KR (254 KB) Portuguese - PT (254 KB) Handling Instructions (2659 KB) References [1]
[35] See also [edit] References [edit] 1 2 3 4 5 6 7 8 9 "FDA approves new treatment for sickle cell disease"
